We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAND
1501
Gladstone Land Corp
LAND
$365M
| $146K | ﹤0.01% |
+14,398
| New | +$141K |
|
1502
Pyxis Oncology
PYXS
$185M
| $146K | ﹤0.01% |
+133,047
| New | +$150K |
|
1503
XBiotech
XBIT
$68.6M
| $142K | ﹤0.01% |
+47,885
| New | +$139K |
|
1504
FIGS
FIGS
$1.76B
| $141K | ﹤0.01% |
+25,037
| New | +$116K |
|
1505
Corbus Pharmaceuticals
CRBP
$165M
| $141K | ﹤0.01% |
+20,437
| New | +$148K |
|
|
CTNM
1506
Contineum Therapeutics
CTNM
$538M
| $140K | ﹤0.01% |
+35,156
| New | +$153K |
|
1507
Drilling Tools International
DTI
$80.5M
| $139K | ﹤0.01% |
+48,715
| New | +$121K |
|
|
RDNW
1508
RideNow Group
RDNW
$256M
| $137K | ﹤0.01% |
+59,394
| New | +$133K |
|
1509
Arcus Biosciences
RCUS
$3.33B
| $137K | ﹤0.01% |
16,794
-14,620
| -47% | -$125K |
|
1510
Amplify Energy
AMPY
$158M
| $132K | ﹤0.01% |
+41,386
| New | +$123K |
|
|
SAND
1511
DELISTED
Sandstorm Gold
SAND
| $132K | ﹤0.01% |
+14,078
| New | +$121K |
|
|
HPP
1512
Hudson Pacific Properties
HPP
$758M
| $132K | ﹤0.01% |
+6,891
| New | +$112K |
|
1513
Kyverna Therapeutics
KYTX
$430M
| $129K | ﹤0.01% |
+42,025
| New | +$104K |
|
1514
Bitdeer Technologies
BTDR
$2.17B
| $129K | ﹤0.01% |
+11,195
| New | +$129K |
|
|
IAUX
1515
i-80 Gold Corp
IAUX
$1.09B
| $127K | ﹤0.01% |
+212,673
| New | +$125K |
|
|
VMEO
1516
DELISTED
Vimeo
VMEO
| $127K | ﹤0.01% |
31,474
-40,744
| -56% | -$189K |
|
|
CRESY
1517
Cresud
CRESY
$806M
| $124K | ﹤0.01% |
+11,621
| New | +$130K |
|
1518
Orchestra BioMed
OBIO
$228M
| $122K | ﹤0.01% |
+45,447
| New | +$133K |
|
|
LOMA
1519
Loma Negra
LOMA
$1.34B
| $121K | ﹤0.01% |
+11,011
| New | +$127K |
|
1520
Commercial Vehicle Group
CVGI
$147M
| $118K | ﹤0.01% |
+70,975
| New | +$86.3K |
|
1521
Array Technologies
ARRY
$740M
| $118K | ﹤0.01% |
+19,946
| New | +$121K |
|
1522
Hudbay
HBM
$9.76B
| $116K | ﹤0.01% |
+10,943
| New | +$91.2K |
|
1523
Vera Bradley
VRA
$98.7M
| $114K | ﹤0.01% |
+51,604
| New | +$106K |
|
1524
Zura Bio
ZURA
$504M
| $113K | ﹤0.01% |
+107,881
| New | +$129K |
|
1525
Akebia Therapeutics
AKBA
$338M
| $112K | ﹤0.01% |
+30,657
| New | +$84.2K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.